Clinical Trials

Showing trials with last updates posted in 2018.

NCT01941329 | COMPLETED | PHASE2/PHASE3
94 participants

Prospective, Randomized, Multicentre, Open-label, Phase II / III Study to Assess Efficacy and Safety of Ranibizumab 0.5 mg Intravitreal Injections Plus Panretinal Photocoagulation (PRP) Versus PRP in Monotherapy in the Treatment of Subjects With High Risk Proliferative Diabetic Retinopathy.

Study Type:
INTERVENTIONAL
Last Updated:
2018-05-14
Start Date:
2014-04-30
Completion:
2016-04-30
Conditions
  • High Risk Proliferative Diabetic Retinopathy
Interventions
  • PROCEDURE
  • DRUG
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page